Basic Information
| LncRNA/CircRNA Name | PANDAR |
| Synonyms | PANDAR, PANDA |
| Region | GRCh38_6:36673621-36675126 |
| Ensemble | ENSG00000281450 |
| Refseq | NR_109836 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | clear cell renal cell carcinoma |
| ICD-0-3 | C64.9 |
| Methods | qPCR, Western blot etc. |
| Sample | clear cell renal cell carcinoma tissues, cell lines (7860 and Caki-1) |
| Expression Pattern | up-regulated |
| Function Description | PANDAR expression was significantly upregulated in tumor tissues and cell lines compared with normal counterparts. Moreover, PANDAR served as an independent predictor of overall survival, and increased PANDAR expression was positively correlated with an advanced TNM stage. |
| Pubmed ID | 28545465 |
| Year | 2017 |
| Title | An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma |
External Links
| Links for PANDAR | GenBank HGNC NONCODE |
| Links for clear cell renal cell carcinoma | OMIM COSMIC |